Skip to main content
. Author manuscript; available in PMC: 2023 Jul 19.
Published in final edited form as: Cell Rep. 2022 Jul 26;40(4):111095. doi: 10.1016/j.celrep.2022.111095

Figure 5. Low NF1 levels correlate with high risk, tumor stage, recurrence, and patient outcome in neuroblastoma.

Figure 5.

Transcript levels of NF1 in high- and low-risk neuroblastoma obtained from the Westermann (A) and SEQC (B) datasets.

(C) NF1 transcript levels in respect to tumor stage obtained from the Kocak dataset.

(D) NF1 transcript levels in respect to relapsed and non-relapsed MYCN-non-amplified NB tumors obtained from the Seeger dataset.

(E) Overall survival probability of patients with high (blue) and low (red) levels of NF1 transcript obtained from SEQC and Kocak datasets.